Dermatology Flashcards
(176 cards)
Risk factors/triggers/exacerbating factors for psoriasis
- Ethnicity - lower rates in Africans, Norwegians and some Asians
- Age - peaks in teenage/young adults and 50-60s
- Strep throat infection
- Other infections e.g. HIV
- Drugs e.g. lithium, beta-blockers, interferon-alpha, chloroquine
- Bone marrow transplant
- Obesity
- Smoking
- Alcohol
- Koebner phenomenon
- Psychogenic factors e.g. stress
Two cardinal histological features of psoriasis
1) Epidermal hyper proliferation
2) Pronounced inflammatory infiltrate
Clinical features of stable chronic plaque psoriasis
- Scaly, red well demarcated plaques
- Most commonly seen on extensor surfaces
- Remitting and relapsing course
- May be associated with psoriatic arthritis
- Increased risk of metabolic syndrome and CVD
Clinical features of guttate psoriasis
- Several hundred small lesions
- Most common on the trunk
- Most common in children and young adults
- 2-3 weeks after strep throat
Psoriatic nail signs
- Nail plate pitting
- Onycholysis
- Oily spots
How would you diagnose psoriasis
- Clinical diagnosis
Management of psoriasis
1) Avoidance of precipitants e.g. smoking cessation, reduce alcohol intake
2) Topical emollients
3) Topical corticosteroids (particularly in flexure and scalp psoriasis)
4) Topical vitamin D analogues
5) Phototherapy
5a) Narrow band UVB phototherapy (works best for small plaque psoriasis)
5b) PUVA therapy
6) Methotrexate
7) Ciclosporin
8) Retinoids (vitamin A analogues)
9) Biologics e.g. TNFa inhibitors or cytokine pathway inhibitor
Side effects of topical corticosteroids
- Skin thinning
- Telangiectasia
- Striae
- Systemic steroid effects with prolonged use
- May loss efficacy over time
Side effects of UBV phototherapy
- Small risk of sunburn
- Potential long-term increased risk of non-melanoma skin cancer
Side effects of PUVA therapy
- Tan
- Increased risk of non-melanoma and melanoma skin cancers
Side effects of methotrexate
- Hepatic fibrosis
- Bone marrow inhibition
- Immunosuppression
- Nausea
- Teratogenic - wait 3 months after stopping treatment two conceive
Monitoring required for patients on methotrexate
- Regular FBC, LFTs and U&Es
Side effects of ciclosporin
- Excessive hair growth
- Gingival hyperplasia
- Immunsuppression
- Nephrotoxicity
- Hypertension
- Increased risk of virally-associated cancers e.g. EBV-lymphoma, HPV-cervical cancer
Side effects of retinoids
- Teratogenic - women should not conceive for 3 years after treatment with acitretin
- Triglyceride elevation
- Increased CVD risk
- Mucosal and cutaneous dryness
- MSK pain
Side effects of biologics
- Immunosuppression
- Virus reactivation
- Worsening of inflammatory disease
3 pathogenic features of acne vulgaris
1) Abnormal keratinisation of the follicular epithelium
2) Increased sebum excretion
3) Infection with gram-positive rod Propionibacterium Acnes
Risk factors for acne
- Male sex
- PCOS
- Congenital adrenal hyperplasia
- Androgen secreting tumour
- Exogenous androgens e.g. steroids
- Family history
Clinical features of acne
- Typically affects the face and upper torso/back
- Includes: comedones, inflammatory papules, pustules, scars
- May have features of hyper-androgenism e.g. hirsutism, androgenic alopecia
Investigations to consider in a patient with acne
- Menstrual history
- Total and free testosterone
- DHEAS
- 17-hydroprogesterone
Management options for acne
1) Topical retinoids (best for comedonal acne)
2) Topical benzoyl peroxide
3) Topical or systemic antibiotics (tetracyclines, erythromycin, clindamycin)
4) Hormonal methods in women e.g. COCP
5) Systemic retinoids (4 month course, dose depends on weight)
Side effects of topical retinoids
- Mild inflammatory reaction e.g. erythema, dryness, scaling
- Teratogenic
Side effects of topical/systemic antibiotics in acne treatment
- Need to be tried for 2 months before considered ineffective
- Tetracyclines CI in <12s - stain teeth and absorbed by bone
- Teratogenic
What tests need to be done before starting a patient on isoretinoin?
- FBC
- Lipid profile
- TFTs
- Pregnancy test
Monitoring required whilst on isoretinoin
- Pregnancy test every month
- Pregnancy test 5 weeks after stopping